Advances in Clinical Chemistry
- 1st Edition, Volume 115 - July 27, 2023
- Imprint: Academic Press
- Editor: Gregory S. Makowski
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 9 2 9 0 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 9 2 9 1 - 3
Advances in Clinical Chemistry, Volume 115, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scient… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteAdvances in Clinical Chemistry, Volume 115, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
- Cover image
- Title page
- Table of Contents
- Advances in CLINICAL CHEMISTRY
- Copyright
- Contributors
- Preface
- Chapter One: Advances in urinary biomarker research of synthetic cannabinoids
- Abstract
- 1 Introduction
- 2 Chemical structures of synthetic cannabinoids
- 3 Pharmacokinetics of synthetic cannabinoids
- 4 In vitro approaches for optimal urinary biomarker identification
- 5 Summary and future perspectives
- References
- Chapter Two: Advances in TB testing
- Abstract
- Abbreviations
- 1 Introduction
- 2 Active tuberculosis
- 3 Latent tuberculosis infection
- 4 Summary and concluding remarks
- References
- Chapter Three: Cardiac markers and cardiovascular disease in chronic kidney disease
- Abstract
- 1 Prevalence of cardiovascular disease in chronic kidney disease
- 2 Cardiac troponins in CKD
- 3 BNP and NT-proBNP in CKD
- 4 Soluble suppression of tumorigenicity 2 (sST2) in CKD
- 5 GDF-15 in CKD
- 6 Gal-3 in CKD
- 7 Other potential biomarkers
- 8 Conclusions
- Declaration of interest
- References
- Chapter Four: microRNA and circRNA in Parkinson’s Disease and atypical parkinsonian syndromes
- Abstract
- 1 Introduction
- 2 Atypical parkinsonian syndromes (APS)
- 3 miRNA and circRNA in PSP and MSA
- 4 miRNA and circRNA based treatment for parkinsonian disorders
- 5 Advantages/limitations and future perspectives
- 6 Conclusions
- References
- Chapter Five: Autoantibodies in psoriatic disease
- Abstract
- 1 Introduction
- 2 Basic principles of antibody assays
- 3 Autoantibodies associated with other inflammatory/autoimmune rheumatic diseases in patients with psoriatic disease
- 4 Novel antibodies described in psoriatic disease
- 5 Clinical significance of autoantibodies in psoriatic disease
- 6 Conclusion
- Acknowledgments
- References
- Chapter Six: Delta checks
- Abstract
- 1 Introduction
- 2 Considerations for delta checks
- 3 Types of error detected by delta checks
- 4 Prerequisites of delta check implementation
- 5 Performance measure of delta check
- 6 Calculating the delta
- 7 Determining the delta check limit
- 8 Determining the look-back period
- 9 Performance verification of delta check
- 10 Delta check in test panels
- 11 Advanced delta check approaches
- 12 Troubleshooting of delta check flags
- 13 Other electronic rules
- 14 Future directions
- References
- Index
- Edition: 1
- Volume: 115
- Published: July 27, 2023
- Imprint: Academic Press
- No. of pages: 232
- Language: English
- Hardback ISBN: 9780443192906
- eBook ISBN: 9780443192913
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect